A ngiotensinogen (AGT; serpin peptidase inhibitor, clade A, member 8) is a glycoprotein that is the primary substrate of the renin-angiotensin-aldosterone system (RAAS) and is, therefore, one of the most frequently studied proteins because of its contributions to hypertension. Given that AGT is the primary substrate controlling the rate-limiting step of the production of angiotensin peptides, a rise in AGT levels can lead to a parallel increase in the formation of the physiologically active enzyme angiotensin II and may ultimately result in multiple diseases, such as hypertension, cardiovascular disease, and kidney injury.
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Recent studies implicate a role for adipose AGT in blood pressure regulation in mice. [12] [13] [14] Glucocorticoids increase angiotensinogen gene expression, 6, 15, 16 whereas the effect of mineralocorticoids on angiotensinogen gene expression is unknown in any type of cell. Circulating AGT derived from adipose tissue is increased in obese hypertension. [17] [18] [19] High salt intake is associated with obesity, 20, 21 suggesting a potential link between high salt intake and increased adipose AGT.
Although many studies have been conducted on the mechanisms of AGT gene regulation, little is known about the contribution of DNA methylation to regulation of the AGT gene. DNA methylation occurs almost exclusively at cytosines of CpG dinucleotides. The patterns of DNA methylation are faithfully replicated at every cell division once they have been established. DNA methylation is associated with the formation of heterochromatin and gene silencing. MECP2 (methylCpG-binding protein 2) is able to directly bind to methylated DNA and repress methylation-based transcription.
In this study, we characterize the epigenetic regulation of the AGT gene. The transcriptional activity of the AGT gene was found to be dependent on DNA methylation. We also found excess circulating aldosterone and high salt intake as a stimulator of adipose angiotensinogen gene expression in humans and rats, respectively. Stimulatory signals caused DNA to be dynamically demethylated and led to chromatin relaxation in the AGT promoter.
Methods
Cell Culture
NCI H295R human adrenocortical cells (ATCC, Manassas, VA) were cultured in DMEM/F12 medium (Sigma Chemical Company, St Louis, MO) supplemented with 2% Ultroser G (Pall Biosepra, NY), 1% ITS+Premix (BD Biosciences, Bedford, MA), and 1% penicillin-streptomycin and maintained at 37°C in a humidified 5% CO 2 incubator.
Human AGT ELISA
To quantify human AGT protein in cell lysate, a human AGT ELISA was performed with a Human angiotensinogen ELISA kit (CUSABIO, Wuhan, China). Cytoplasmic extracts were isolated from H295R cells. Data were normalized to the total protein concentration of the cytoplasmic extracts.
Real-Time Reverse Transcription Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction (PCR) was performed using the SYBR Green method. ACTB (actin, beta) and Rn18s (18S ribosomal RNA) were used as the reference genes for humans and rats, respectively. The primer sequences were as follows: human AGT: forward 5′-CCCTGGCTTTCAACACCTAC-3′, reverse 5′-GCTGTTGTCCACCCAGAACT-3′; human ACTB: forward 5′-TGGC ACCCAGCACAATGAA-3′, reverse 5′-CTAAGTCATAGTCCGCCT AGAAGCA-3′; rat Agt: forward 5′-AGCACGGACAGCACCCTATT, reverse 5′-AGAACTCATGGAGCCCAGTCA-3′; rat Rn18s RNA: forward 5′-ACGGAAGGGCACCACCAGGA-3′, reverse 5′-CACCAC CACCCACGGAATCG-3′.
Bisulfite Sequencing
Genomic DNA was treated with bisulfite and amplified with primers specific for the human AGT and rat Agt promoter regions. The human AGT promoter regions spanning from −483 to −130 and from −110 to +78 were amplified with the following primer pairs:
forward 5′-GTTGAAGGTTATATATTTTATGAG-3′, reverse 5′-AATACCAAAAACGACACTC-3′ (−483 to −130) and forward 5′-GGTTTGGTTAAGTGATGTAA-3′, reverse 5′-AAAAACAAAACCGAAAAA-3′ (−110 to +78). The rat Agt promoter regions spanning from −400 to −103 and from −57 to +236 were amplified with the following primer pairs: forward 5′-AATTTGATTAGATGTGTTAGAAG-3′, reverse 5′-TTACATATTTACCCCAATTC-3′ (−400 to −103) and forward 5′-TGAAGTTTATTTGTTATTAGGGTTTTT-3′, reverse 5′-AAACTCAACTCCTACCCAATCA-3′ (−57 to +236). Eight cloned PCR products were chosen for analysis of CpG methylation status, as previously described.
22-24
Chromatin Accessibility by Real-Time PCR H295R cells were cultured in 48-well plates to 80% to 95% confluence before they were digested in situ with or without nuclease at 37°C for 1 hour, in accordance with the protocol for the EpiQ Chromatin Analysis Kit (BIORAD, Hercules, CA). The cells were subsequently lysed and genomic DNA was isolated. One hundred nanograms of genomic DNA was used to perform SYBR Green real-time PCR (qPCR) for the AGT gene and the reference gene. Each PCR was performed in duplicate. The qPCR data were analyzed with the data analysis tool of the EpiQ Chromatin Analysis Kit to determine the chromatin accessibility within the AGT promoter region (Figure 1 ). The human AGT promoter regions were amplified with the following primer pairs: forward 5′-CCCGTTTCTGGGAACCTT-3′, reverse 5′-AGATGCCAGAAGCGACACTC-3′ (R2; CEBP); forward 5′-CAGCTATAAATAGGGCATCGTG-3′, reverse 5′-ACAA GACCGAGAAGGAGCTG-3′ (R1; transcription start site); forward 5′-TTGCCTAAGCAAGACTCTCC-3′, reverse 5′-GGAG ATGTACCCCCAAGAGG-3′ (R3; CpG3); forward 5′-GAGCAG CTGAAGGTCACACA-3′, reverse 5′-GCAGGGGAGAGTCTTG CTTA-3′ (R4; CpG1,2).
Chromatin Immunoprecipitation Quantitative PCR
The chromatin immunoprecipitation (ChIP) assays were performed with the LowCell# ChIP Kit (Diagenode Diagnostics, Liège, Belgium) in accordance with the manufacturer's protocol. Anti-CEBP-β (Anti-CEBPB) polyclonal antibody (sc-150; Santa Cruz Biotechnology, Dallas, TX) and IgG (sc-2027; Santa Cruz Biotechnology) were used. Quantification of ChIP DNA was accomplished by qPCR with primers specific for the AGT promoter region around the CEBPB transcription factor binding site; the primer sequences are the same as those used for the chromatin accessibility by real-time PCR assay. The results are presented as fold enrichment of IgG. Each sample was amplified in triplicate and all experiments were repeated ≥3×.
DNA Methylation Activity Assay
Using the EpiQuik DNA Methyltransferase Activity/Inhibition Assay Kit (Epigenetic, Farmingdale, NY), DNA methylation activity was quantified as the ability of nuclear extracts to methylate DNA substrate. The methylated DNA was recognized with an anti-5-methylcytosine antibody. Each sample was measured in triplicate.
DNA Demethylation Activity Assay
Using the EpiQuik DNA Demethylase Activity/Inhibition Assay Ultra Kit (Epigenetic), DNA demethylation activity was quantified as the ability of nuclear extracts to demethylate methylated DNA substrate. The methylated DNA was recognized with an anti-5-methylcytosine antibody. Each sample was measured in triplicate.
Statistical Analysis
Statistical significance of the differences between experimental groups was analyzed by using Student t test, 1-way ANOVA, or 2-way ANOVA. The data are expressed as mean±SEM. P values <0.05 were considered to be statistically significant.
Results
IL6 Treatment Results in DNA Demethylation Around a CEBP Binding Site and a Transcription Start Site
We analyzed the DNA methylation status of 17 of 18 CpG dinucleotides within a 525-bp fragment (−459 to +66) of the human AGT promoter, which contains 1 CEBP binding site ( Figure 1 ). We sought to gain insight into dynamic changes in DNA demethylation of the AGT promoter. IL6 has been shown to stimulate AGT expression. 25, 26 IL6 treatment upregulated AGT expression in a dose-dependent manner in H295R cells (data not shown). A preliminary comparison of DNA Figure 2A ). Gray circles indicate the A allele of the G-6A polymorphism (rs5051). The −6G allele becomes a CpG dinucleotide, a canonical target site for DNA methylation. The results strongly indicated that H295R cells had −6AA genotype. Unmethylated or methylated cytosines were observed probably because errors happened in bisulfite sequencing or mutations occurred in H295R cells.
IL6 Treatment Increases AGT Expression
AGT mRNA levels gradually increased during IL6 stimulation and decreased to a level that was similar to that of nontreated cells after stimulation. AGT mRNA levels in cells treated with IL6 were significantly higher than those in nontreated cells at 12, 24, 30, and 36 hours after stimulation ( Figure 2B ). Similar changes were observed in the levels of AGT protein. At 24 hours after stimulation, AGT protein levels in cells treated with IL6 were significantly higher than those in nontreated cells ( Figure 2C ).
IL6 Treatment Recruits CEBPB to the AGT Promoter Region
DNA hypomethylation at a CEBP binding site has been observed in tissues with elevated expression of AGT, and the site was demethylated during IL6 treatment. These observations suggest an association between CEBP and changes in DNA methylation. We used a ChIP assay to determine that the binding of CEBPB to the AGT promoter in cells treated with IL6 was significantly higher than that in nontreated cells. A steep increase in recruitment of CEBPB to the AGT promoter was observed during IL6 treatment. Five days after stimulation, CEBPB binding in cells treated with IL6 had decreased to a level that was similar to levels in nontreated cells ( Figure 3 ).
IL6 Treatment Increases Chromatin Accessibility of the AGT Promoter
Treatment of H295R cells with IL6 increased recruitment of CEBPB to its binding site in the AGT promoter. CEBPB has been characterized as a pioneering factor that binds to chromatin-embedded DNA and recruits remodeling proteins. 27 Chromatin accessibility may be important for dynamic changes in DNA demethylation and remethylation in a locus-specific manner. Chromatin accessibility by real-time PCR revealed that IL6 treatment significantly increased chromatin accessibility around a transcription start site (R1) at 6, 12, and 24 hours after stimulation, with accessibility increasing from 58% to 79% ( Figure 4A ). Chromatin accessibility around a CEBP binding site (R2) also increased, to ≈80%. At 24 hours after stimulation, the accessibility of treated cells was significantly different from that of cells in the control group ( Figure 4B ). After stimulation, the accessibility of both regions returned to levels that were similar to those of the control group.
In contrast, chromatin accessibility did not increase around the CpG3 (R3; Figure 4C ) or CpG1/2 (R4) sites ( Figure 4D ). The accessibility of both regions was consistently <40%; this percentage indicates that the chromatin was accessible at a low level or was even highly inaccessible.
IL6 Treatment Reduces DNA Methylation Activity
We used a time-course analysis to determine DNA methylation and demethylation activities in nuclear extracts from H295R cells. IL6 treatment significantly reduced DNA methylation activity at 12, 24, 30, 36, and 48 hours after stimulation ( Figure 5A ). No obvious differences in DNA demethylation activity were observed between IL6-treated cells and those of the control group ( Figure 5B) . These results suggest a potential role for decreased DNA methylation activity during the process of DNA demethylation and remethylation.
Discussion
In contrast with readily reversible histone modifications, DNA methylation was generally accepted to be a relatively static epigenetic modification. Recent findings, however, support the emerging concept that DNA methylation patterns are not always stable. [28] [29] [30] DNA methylation is a well-known mechanism for gene silencing, but comparatively little is known about where changes in DNA methylation occur and how DNA methylation is rapidly reversed in a locus-specific manner. Our study revealed that the stimulatory signals of IL6, excess circulating aldosterone, and high salt intake all led to DNA demethylation around a CEBP binding site and a transcription start site, where chromatin structure was relaxed. DNA demethylation was detected within 12 hours after IL6 treatment, whereas the highest level of demethylation was evident by 24 hours.
Irrespective of the type of stimuli, DNA demethylation around a CEBP binding site and a transcription start site in the angiotensinogen gene promoter was accompanied by increased angiotensinogen gene expression in both humans and rats. The CEBP family of proteins has been reported to pioneer chromatin remodeling and maintain chromatin accessibility. 11 Taken together, our findings indicate that CEBP family members initiate chromatin relaxation and transcription, which are followed by DNA demethylation around a CEBP binding site and a transcription start site in the angiotensinogen gene promoter.
The molecular regulatory effects of IL6 on AGT expression have been extensively investigated in human liver cells. In addition to CEBP family members, NR3C1, STAT3, and HNF1A that bind to the nucleotide sequence located between −162 and −278 of the AGT promoter are involved in IL6-induced activation of AGT ( Figure S4A) . 31 Because the AGT promoter was fully unmethylated in human liver HepG2 cells, we were unable to use these cells to analyze changes in DNA methylation ( Figure S2 ). Instead, we used human adrenocortical H295R cells that had a partially methylated AGT promoter (Figure 2A) . In H295R cells, IL6 treatment upregulated AGT expression in a similar manner with HepG2 cells and was accompanied by extensive demethylation from CpG5 (−281/−282) to CpG11 (−152/−153; Figure 2A ). These results suggest that transcription factors CEBP, NR3C1, STAT3, and HNF1A may be involved in the upregulation of AGT and DNA demethylation of this gene promoter in H295R cells as is the case with human liver cells.
We have shown for the first time that circulating aldosterone in patients with aldosterone-producing adenoma (APA) leads to increased AGT expression in visceral adipose tissue ( Figure  S5C ). Aldosterone is ≈1000× less than cortisol in the circulating blood (Table S1 ). Aldosterone and cortisol, although both corticosteroids, regulate AGT differently: aldosterone is a more potent activator of AGT expression than is cortisol. RAAS is a system of major importance in the control of fluid and electrolyte homeostasis. Thus, aldosterone seems to exert a physiologically relevant effect on AGT expression. This positive feedback effect may be an innate capacity to efficiently retain fluid in land dwelling mammalian species. Excessive salt in contemporary diets depresses the circulating RAAS. 32 DNA hypermethylation of the AGT promoter in adipose tissue from NFA (non-functioning adrenocortical adenoma) may reflect depressed levels of the circulating RAAS in contemporary humans.
Two receptor systems, the glucocorticoid receptor system (NR3C1) and the mineralocorticoid receptor system (NR3C2), differentially modulate corticosteroid actions in adipose tissue. 33 Glucocorticoid receptor and mineralocorticoid receptor bind to a common corticosteroid response element. The CEBP binding site (−217 to −225) is also known to interact with corticosteroid receptors. 6 CEBPB and glucocorticoid receptor have been reported to cooperatively and specifically regulate
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A CpG dinucleotide at the CEBP binding site (−217 to −225) was hypomethylated in adipose tissue of patients with APA, whereas this site was hypermethylated in the tissue of patients with Cushing syndrome (CS; Figure S5A and S5B). The difference in DNA methylation at the CEBP binding site between patients with APA and those with CS suggests differential actions of corticosteroids in human adipose tissue via interactions between corticosteroid receptors and CEBP. Glucocorticoids are well-known activators of angiotensinogen gene expression in humans and rodents. 6, 15, 16 Three putative corticosteroid response elements (gtccct, −371 to −376; ctctg, −393 to −397; ctctg, −400 to −404) exist in the vicinity of CpG2 and CpG3 ( Figure S4A ). DNA hypomethylation at CpG2/3 sites and around a transcription start site was observed in visceral adipose tissue of patients with CS. Cortisol-induced recruitment of corticosteroid receptors might cause DNA demethylation at these 2 CpG sites and activate AGT transcription in cases of CS. Hypertension is a prominent characteristic of APA and CS. Although elevation in arterial pressure is primarily induced by aldosterone and cortisol in APA and CS, respectively, increased AGT expression from visceral adipose tissue may contribute, in part, to the development of hypertension in both conditions.
High salt intake suppresses the circulating RAAS. Salt intake can affect sympathetic nerve activity and lead to changes in the gene expression profile of adipose tissue. Agt expression was paradoxically increased in visceral adipose tissue from Wistar-Kyoto rats fed a high-salt diet ( Figure  S6D ). This result suggests that salt-dependent hypertension in humans may be, in part, dependent on increased AGT expression in visceral adipose tissue. More importantly, DNA hypomethylation at CEBP binding sites and a transcription start site coincided with increased Agt expression in rat visceral adipose tissue ( Figure S6A-S6D ). This finding indicates that a close association exists between DNA hypomethylation at CEBP binding sites and increased angiotensinogen gene expression in both humans and rats. We have shown that DNA methylation at CpG dinucleotides alters gene expression by affecting transcription factor binding activity. 23 However, the effects of CpG methylation on binding activities of transcription factors with the AGT promoter were limited ( Figure S4B and S4C) . CpG methylation increased MECP2 binding activities with the AGT promoter ( Figure S4D ). These observations suggest that MECP2 recruitment to methylated CpG dinucleotides would play a crucial role in transcriptional repression of AGT by DNA methylation.
Functional DNA demethylation is accompanied by chromatin accessibility. 34 Subtle change in topology of nucleosomal DNA in promoter regions can play an important role in gene regulation. 35 After IL6 stimulation, we detected an open chromatin structure only around a transcription factor binding site and a transcription start site. Thus, chromatin accessibility plays a crucial role in gene regulation.
DNA methylation is established and maintained by DNA methyltransferases. DNA methyltransferase 3A and 3B are responsible for de novo DNA methylation, whereas DNA methyltransferase 1 maintains DNA methylation patterns through successive rounds of cell division. 36 DNA demethylation can occur through an active or passive pathway. Active DNA demethylation is the postulated process whereby 5-methylcytosine is sequentially modified, excised, and replaced by the DNA repair machinery. By contrast, passive DNA demethylation refers to the loss of the methyl radical from 5-methylcytosine when DNA methyltransferase 1 is inhibited or absent during successive rounds of DNA replication. 37 In our study, DNA demethylation of the AGT promoter was associated with decreased DNA methylation activities ( Figure 5A ; Figure S6E ). This association suggests that passive, rather than active, DNA demethylation may be a more likely cause. The balance between DNA methylation and demethylation activities may be a major determinant for DNA methylation status.
Perspectives
Stimulatory signals can orchestrate locally transcription factor recruitment, open chromatin configuration, and DNA demethylation in a locus-specific manner and globally a reduction in DNA methylation activity in the nucleus. Any type of continuous signal could elicit changes in DNA methylation to globally control the balance between DNA methylation and demethylation activities. DNA methylation status can be used to trace the amount of chromatin that is opened by transcription factors at specific sites and functions as a memory to maintain responsiveness of gene expression to additional signals. DNA demethylation converts the gene expression phenotype within a tissue from an inactive to an active state ( Figure 6 ). 
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What Is New?
• We demonstrate dynamic changes of DNA methylation as to where changes in DNA methylation occur and how rapidly DNA demethylation and remethylation progress in the angiotensinogen gene (AGT) promoter.
• Excess circulating aldosterone and high salt intake upregulate adipose AGT expression in humans and rats, respectively.
What Is Relevant?
• Increased AGT expression from visceral adipose tissue may contribute to the development of hypertension in APA (aldosterone-producing adenoma) and CS.
• Salt-dependent hypertension may depend on increased AGT expression in visceral adipose tissue. 
Luciferase assay
SssI methylase (New England Biolabs Japan Inc., Tokyo, Japan) was used for in vitro methylation of AGT promoter luciferase constructs in the pGL4.10 vector. In each case, half of the DNA sample was methylated using SssI and the other half was incubated with SssI methylase in the absence of S-adenosylmethionine (mock-methylation). The efficiency of methylation or mock-methylation was determined through digesting modified constructs with restriction endonuclease BsiEi (New England Biolabs Japan Inc., Tokyo, Japan). Adrenocortical H295R cells were transfected using FuGene HD (Roche Laboratories, Basel, Switzerland) with the following plasmids: (1) 100 ng of modified pGL4.10 firefly luciferase reporter plasmid containing methylated or unmethylated AGT promoter and (2) 10 ng of pRL-TK Renilla luciferase control reporter vector that contains a cDNA encoding Renilla luciferase (Promega, Madison, WI, USA) as an internal control for transfection efficiency. The day before transfection, H295R cells were seeded onto a 96-well plate and transfected at 80% confluency. Cells were incubated for 48h following transfection. Firefly and Renilla luciferase assays were performed using 10ul of cell lysates and a dual-luciferase reporter assay system kit (Promega). Results are reported as the average of triplicate assays and are expressed as a ratio to the internal standard Renilla luciferase.
Enzyme-linked immunosorbent assay-based electrophoretic mobility shift assay (NoShift assay) Nuclear extracts were isolated from H295R cells and HepG2 cells according to the manufacturer's protocol with the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific, Yokohama, Japan). Protein concentration was determined using a BCA protein assay (Thermo Fisher Scientific) with BSA as a standard. The enzyme-linked immunosorbent assay-based electrophoretic mobility shift assay was carried out using 
Procurement of human tissue
Visceral adipose tissue surrounding the adrenal gland was obtained from 27 patients including 10 patients with aldosterone-producing adenoma (APA), 7 patients with Cushing syndrome (CS), and 10 patients with non-functioning adrenocortical adenoma (NFA) (Supplementary Table S1 ). Human tissue samples were obtained from Kanazawa University Hospital (Kanazawa, Japan), Tohoku University Hospital (Sendai, Japan), and Ishikawa Central Prefectural Hospital (Kanazawa, Japan). All samples were frozen in liquid nitrogen and stored at -80°C. All experimental protocols were approved by the Institutional Review Boards of Kanazawa University, Tohoku University, and Ishikawa Central Prefectural Hospital. The purpose of the study was explained to all patients, and written informed consent was obtained from each study participant.
Animal experiments
Visceral adipose tissue was obtained from Wistar Kyoto (WKY) rats that were fed either low-sodium (0.45%) or high-sodium (7%) chow for 8 weeks (n= 5, each group). All experiments were performed in accordance with the guidelines for the use of experimental animals of the Animal Research Committee of Kanazawa University.
Results
DNA methylation within a CEBP binding site appears to be inversely associated with AGT expression in human tissues
AGT expression is high in the liver, heart, and brain, compared to the adrenal gland ( Supplementary Fig. S1 ). Bisulfite sequencing showed that a CpG dinucleotide within the CEBP binding site was hypomethylated in tissues from the liver and heart, whereas hypermethylated in those from the adrenal gland and leukocytes (Supplementary Fig. S2 ). CpG dinucleotides within the AGT promoter region were completely unmethylated in the human liver cell line, HepG2. Thus, methylation status of a CpG dinucleotide within the CEBP binding site appeared to be inversely associated with AGT expression.
DNA methylation strongly represses the AGT promoter activity
To assess the effect of DNA methylation on the AGT transcriptional activity, we synthesized luciferase reporter constructs containing varying lengths of the AGT promoter either with or without CpG methylation ( Supplementary Fig. S3A ). We used constructs with AA at -6 (rs5051), AA at -20 (rs5050) and GG at -217 (rs5049). DNA methylation abolished the AGT promoter transcription activities ( Supplementary Fig. S3B ), indicating the AGT promoter was dependent on DNA methylation. Fig. S4A ). There is now abundant evidence that DNA methylation affects DNA-protein interactions and may have a function in all processes in which such interactions occur. We performed in vitro analysis to determine the functional significance of methylation in the AGT promoter region by analysing the binding potential of methylated or unmethylated oligonucleotides (analogous to putative AGT regulatory elements) to nuclear proteins from H295R and HepG2. NoShift assay showed DNA methylation impaired USF1 binding at -20 with A or C in both cell lines. However, DNA methylation had little effects on activators ESR1, CEBPB, NR3C1 and HNF4A binding to the corresponding elements ( Supplementary  Figs. S4B and C) . DNA methylation increased NR2F1 binding in HepG2 cells (Supplementary Fig. S4C ) and MECP2 binding in both cell lines ( Supplementary Fig. S4D ).
DNA methylation affects DNA-protein interaction in vitro
Excess circulating aldosterone induces DNA demethylation of the AGT promoter and increases mRNA levels in human adipose tissue We simultaneously determined the DNA methylation status and mRNA levels of the AGT gene in visceral adipose tissue from patients with APA, CS, and NFA. The AGT promoter, including 1 CEBP binding site, was largely unmethylated in patients with APA ( Supplementary Fig. S5A and B); this finding contrasts with those in patients with CS and NFA. AGT mRNA levels in adipose tissue were consistently higher in patients with APA than in patients with NFA ( Supplementary Fig. S5C ). These results demonstrate that excess circulating aldosterone leads to demethylation of the AGT promoter, including the CEBP binding site and the transcription start site, and activation of the AGT gene in human adipose tissue. DNA at CpG2/3 and DNA around a transcription start site (CpG12 to 15) were both hypomethylated in adipose tissue of patients with CS, and the levels of methylation were comparable to that in the tissue of patients with APA ( Supplementary Fig. S5A and B) . Although the difference was not statistically significant, AGT mRNA levels in adipose tissue tended to be higher in patients with CS than in patients with NFA ( Supplementary Fig. S5C ).
Although to a lesser extent than with aldosterone, excess circulating cortisol also leads to demethylation and upregulation of AGT.
High salt intake induces DNA demethylation of the Agt promoter and increases mRNA levels in rat adipose tissue We analyzed the DNA methylation status of 12 out of 13 CpG dinucleotides within a 571 bp fragment (-364 to +207) of the rat Agt promoter, which contains 2 CEBP binding sites (cttgctcca, +2 to +10; ctgggaa, +78 to +84; Supplementary Fig. S6A ). We simultaneously determined both DNA methylation status and mRNA levels of the Agt gene in visceral adipose tissue from Wistar-Kyoto rats fed either a high-or low-salt diet. CpG dinucleotides around the CEBP binding sites and a transcription start site were hypomethylated in rats fed a high-salt diet ( Supplementary Fig. S6B and C). Levels of Agt mRNA were consistently higher in rats fed a high-salt diet than in those fed a low-salt diet ( Supplementary Fig. S6D ). These results demonstrate that high salt intake leads to demethylation of CEBP binding sites and a transcription start site of the Agt promoter and activation of the Agt gene in rat visceral adipose tissue, as was observed at the AGT promoter of human visceral adipose tissue. DNA methylation activity in nuclear extracts was significantly lower in rats fed a high-salt diet than in those fed a low-salt diet ( Supplementary Fig. S6E ). No significant differences in DNA demethylation activity were observed between rats fed either a high-or low-salt diet ( Supplementary Fig. S6F ). A high salt intake-induced decrease in DNA methylation activity may play a crucial role in DNA demethylation of the Agt promoter.
